Increased Serum Angiotensin II Is a Risk Factor of Nonalcoholic Fatty Liver Disease: A Prospective Pilot Study

Table 1

Clinical and laboratory characteristics of the study patients divided into two groups according to abdominal ultrasound results. Significant values are in bold.

Variables	Control group ()	NAFLD group ()	value
Age (years)			0.572
Gender (male, %)	33, 67.35%	40, 85.11%	0.056
Body weight (kg)			<0.001
BMI value			<0.001
ALT (U/L)			0.001
AST (U/L)			0.270
Albumin (g/L)			0.171
CRP (mg/L)			0.131
TG (mmol/L)			<0.001
CHOL (mmol/L)			0.702
HDL (mmol/L)			0.005
LDL (mmol/L)			0.747
VLDL (mmol/L)			<0.001
FBG (mmol/L)			0.061
Serum insulin (mIU/L)			<0.001
HOMA-IR			<0.001
Ang II (pg/mL)			0.014
PRA (pg/mL)			0.311
ALD (pg/mL)			0.142
PRA/ALD			0.565
IL-18 (pg/mL)			0.045
IL-1β (pg/mL)			0.049